Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Inbiomotion logo — Perspective from knowledge

Inbiomotion

Perspective from knowledge

Founded 2010 Spain Spain 12 employees Series Unknown Total: $4.25M Biotechnology, Health Care +1

General Information

Company Name Inbiomotion
Founded Year 2010
Location Spain Spain +1
Founders / Decision Makers
Team member Team member
Employees 12
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series Unknown
Social

Get notified when Inbiomotion moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Inbiomotion

Inbiomotion is a biotechnology startup based in Spain, founded in 2010. The company's slogan, "Perspective from knowledge," reflects its commitment to providing objective insights into patients' MAF gene levels. Their test aims to empower pathologists and oncologists with vital information, enabling effective and efficient treatment with bisphosphonates while minimizing the risk of relapse. Their recent Venture Round investment on 21 January 2021 attracted the attention of Alta Life Sciences and ICF Capital, showcasing confidence in the company's potential. With a focus on driving clinical results, Inbiomotion aims to advance precision medicine and make a meaningful impact in the field of healthcare.

Taxonomy: precision medicine, oncology, MAF gene, clinical testing, pathology, biomarker, cancer treatment, bisphosphonates, genetic testing, risk assessment, relapse prevention, clinical insights, medical innovation

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 2
Investor
•••• •••• 		21 Jan 2021
Series B •••••• 3
Investor Investor
•••• •••• 		13 Mar 2016
Grant •••••• 1 •••• •••• 01 Mar 2016
Series A •••••• 1
Investor
28 Jun 2012

Inbiomotion Alternatives & Competitors

Inbiomotion vs
Sebia
Sebia France

A Global specialized In Vitro Diagnostic player

Private Equity
555 employees
Biotechnology, Health Care
Inbiomotion vs
Biocept, Inc.
Biocept, Inc. United States

Helping physicians improve outcomes for metastatic cancer patients by delivering advanced diagnostic...

Post Ipo Equity
49 employees
Biotechnology, Health Care
Inbiomotion vs
ARTPred
ARTPred The Netherlands

ReceptIVFity Fertility Microbiome Profiling

Grant
4 employees
Biopharma, Biotechnology

FAQ About Inbiomotion

Perspective from knowledge
Inbiomotion was founded in 2010.
Inbiomotion is headquartered in Spain.
Inbiomotion operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Inbiomotion has approximately 12 employees.
Inbiomotion has completed 4 funding rounds, raising a total of $4.25M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Inbiomotion include Sebia, Biocept, Inc. , ARTPred, Quest Diagnostics, Luxor Scientific. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Inbiomotion and Sebia are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Inbiomotion and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy